22nd Century Group (XXII)

Add to Watchlists
Create an Alert
0.8199 +0.00  +0.48% NYSE MKT Apr 29, 21:57 Delayed 2m USD
View Full Chart
XXII Price Chart
View All Performance Charts

XXII Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.xxiicentury.com
  • Investor Relations URL: http://www.xxiicentury.com/irtools/
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry Name: Scientific Research and Development Services
  • NAICS Sector Name: Professional, Scientific, and Technical Services
  • Profile: 22nd Century Group, Inc. is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

XXII Comparables

Edit

XXII Excel Add-In Codes

  • Name: =YCI("XXII","name")
  • Description: =YCI("XXII","description")
  • Sector: =YCI("XXII","sector")
  • Industry: =YCI("XXII","industry")
  • Est. Current Fiscal Year End: =YCI("XXII","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.